MoonLake Immunotherapeutics (MLTX)
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian R
客服专线︰ +852 3018 4526
交易日︰全日24小时 | 非交易日：9:00-18:00
